AUGUSTUS Demonstrates Favorable Safety Results of Eliquis Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome...
PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Mar 17, 2019--The Bristol-Myers Squibb - Pfizer Alliance today announced results from the Phase 4 AUGUSTUS trial evaluating Eliquis (ap…
